Document Detail

Effect of intravenous propacetamol on blood pressure in febrile critically ill patients.
MedLine Citation:
PMID:  18823215     Owner:  NLM     Status:  MEDLINE    
STUDY OBJECTIVES: To investigate the effect of intravenous propacetamol, a parenteral bioprecursor of acetaminophen, on systemic blood pressure in critically ill patients with fever, and to establish the prevalence and clinical significance of this effect. DESIGN: Prospective, observational study. SETTING: A six-bed medical-surgical intensive care unit (ICU) of a university-affiliated tertiary care hospital in Israel. PATIENTS: Fourteen critically ill patients (aged 17-83 yrs) with sepsis and fever (body temperature > or = 38 degrees C) who received an intravenous infusion of propacetamol 2 g over 15-20 minutes every 6 hours as needed to reduce fever. MEASUREMENTS AND RESULTS: Demographic data, including degree of sepsis, were collected at baseline (before propacetamol infusion). Blood pressure, heart rate, body temperature, and need for fluid or vasopressor therapy were recorded at baseline, at end of infusion, and at 15, 30, 45, 60, 90, and 120 minutes after propacetamol administration. The drug was administered on 72 occasions in the 14 patients. Mean +/- SE systolic, diastolic, and mean arterial pressures recorded 15 minutes after propacetamol administration were significantly lower than baseline measurements: 123 +/- 29 versus 148 +/- 33, 62 +/- 12 versus 70 +/- 15, and 83 +/- 16 versus 97 +/- 19 mm Hg, respectively (p<0.05). In 24 (33%) of the 72 infusions, systolic blood pressure decreased to below 90 mm Hg and required intervention with fluid bolus administration on six occasions; a fluid bolus was accompanied by a dosage increase or initiation of a norepinephrine infusion on 18 occasions. No correlation, however, was noted between the degree of decrease in mean arterial pressure and decrease in temperature (r(2)=0.01), or the degree of decrease in mean arterial pressure and decrease in heart rate (r2=0.23), at each data collection time point, as measured by linear regression. CONCLUSION: Intravenous propacetamol, given in antipyretic doses, caused a significant decrease in blood pressure 15 minutes after administration in febrile critically ill patients. This drug-induced hypotension was clinically relevant in that interventions to control blood pressure were required. Thus, clinicians should be aware of this potential deleterious effect, particularly in specific populations such as critically ill patients.
Moshe Hersch; David Raveh; Gabriel Izbicki
Related Documents :
18945325 - Treatment time, chronic inflammation, and hemodynamic stability: the overlooked paramet...
15256675 - Long-term angiotensin-converting enzyme inhibitor perindopril therapy improves cerebral...
18823215 - Effect of intravenous propacetamol on blood pressure in febrile critically ill patients.
1609765 - Effects of alterations in fatty acid intake on the blood pressure of adolescents: the e...
15019645 - Histidine-tryptophan-ketoglutarate solution maximally preserves endothelium-derived hyp...
20803605 - Understanding size enlargement and hardening of granules on tabletability of unlubricat...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pharmacotherapy     Volume:  28     ISSN:  0277-0008     ISO Abbreviation:  Pharmacotherapy     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-09-30     Completed Date:  2009-01-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111305     Medline TA:  Pharmacotherapy     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1205-10     Citation Subset:  IM    
Critical Care Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acetaminophen / analogs & derivatives*,  pharmacology,  therapeutic use
Aged, 80 and over
Analgesics, Non-Narcotic / pharmacology*,  therapeutic use
Blood Pressure / drug effects*
Critical Illness
Fever / drug therapy*,  physiopathology
Infusions, Intravenous
Middle Aged
Prodrugs / pharmacology*,  therapeutic use
Prospective Studies
Sepsis / physiopathology
Young Adult
Reg. No./Substance:
0/Analgesics, Non-Narcotic; 0/Prodrugs; 103-90-2/Acetaminophen; 66532-86-3/propacetamol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Improving accuracy in detecting acoustic onsets.
Next Document:  Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.